Although the relationship between these species and HPV infection in HNCs is still unclear, by blocking programmed cell death ligand-1 and enhancing the function of T cells, durvalumab may guard against infection-causing species while having minimal effects on the overall salivary microbial composition, representing more than 700 bacterial species [46]. Here, CD274 is linked to infection.